PHOENIX group is the largest European Healthcare Provider covering 27 markets with pharmaceutical wholesale, healthcare logistics and more than 2,500 own pharmacies and more than 13,500 cooperation pharmacies.
“This partnership opens new opportunities for both sides,” says Oliver Windholz, CEO PHOENIX group, “We are happy to work closely together to give European patients access to Pharmascience’s world-class branded and generic products.”
Founded by two pharmacists in 1983, Pharmascience is one of the leading Canadian manufacturers of generic and branded drugs and is active in over 60 countries.
“We are happy to partner with one of the biggest European healthcare providers to expand our activities in the important European markets,” says Jean-Guy Goulet, Chief Operating Officer of Pharmascience.
Phoenix will provide wholesale, market access and sales services across Central Eastern Europe (CEE) and the signature of this agreement represents a key milestone of our market entry strategy in the region.